IS5482A - Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp - Google Patents

Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp

Info

Publication number
IS5482A
IS5482A IS5482A IS5482A IS5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A
Authority
IS
Iceland
Prior art keywords
dementia
tetrahydropyridine
alzheimer
treatment
composition
Prior art date
Application number
IS5482A
Other languages
English (en)
Inventor
Maffrand Jean-Pierre
Soubrie Philippe
Terranova Jean-Paul
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of IS5482A publication Critical patent/IS5482A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS5482A 1997-11-14 2000-05-09 Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp IS5482A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
PCT/FR1998/002384 WO1999025363A1 (fr) 1997-11-14 1998-11-09 Association de principes actifs, notamment de tetrahydropyridines et d'agents inhibiteurs de l'acetylcholinesterase, pour le traitement de la demence senile du type alzheimer

Publications (1)

Publication Number Publication Date
IS5482A true IS5482A (is) 2000-05-09

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5482A IS5482A (is) 1997-11-14 2000-05-09 Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp

Country Status (27)

Country Link
EP (1) EP1030671A1 (is)
JP (1) JP2001523642A (is)
KR (1) KR100599350B1 (is)
CN (1) CN1243540C (is)
AU (1) AU743228B2 (is)
BG (1) BG64819B1 (is)
BR (1) BR9814035A (is)
CA (1) CA2309966A1 (is)
CO (1) CO4980891A1 (is)
DZ (1) DZ2649A1 (is)
EA (1) EA003255B1 (is)
EE (1) EE04235B1 (is)
HU (1) HUP0100098A3 (is)
ID (1) ID24933A (is)
IL (2) IL136122A0 (is)
IS (1) IS5482A (is)
MY (1) MY120461A (is)
NO (1) NO20002450L (is)
NZ (1) NZ504420A (is)
OA (1) OA11464A (is)
PL (1) PL194597B1 (is)
SA (1) SA98190747B1 (is)
SK (1) SK286040B6 (is)
TR (1) TR200001262T2 (is)
TW (1) TW585766B (is)
UY (1) UY25247A1 (is)
WO (1) WO1999025363A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100375619C (zh) * 2002-06-14 2008-03-19 富山化学工业株式会社 改善脑功能的药物组合物及其用途
PT1529116E (pt) * 2002-08-07 2009-09-10 Novartis Ag Métodos para o tratamento da demência com base no genótipo da apo e
CN1520818A (zh) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
JP2008525313A (ja) 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
DK3498692T3 (da) 2014-01-31 2022-05-16 Cognition Therapeutics Inc Isoindolin-sammensætninger og fremgangsmåder til behandling af neurodegenerativ sygdom og makulær degeneration
BR112019023851A2 (pt) * 2017-05-15 2020-08-18 Cognition Therapeutics, Inc. compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas
WO2019182319A1 (ko) * 2018-03-20 2019-09-26 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
KR102224917B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
CN1126546C (zh) * 1995-03-06 2003-11-05 英特纽隆制剂药有限公司 使用胞磷胆碱减少梗塞面积
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
HUP0100098A3 (en) 2001-12-28
EE04235B1 (et) 2004-02-16
KR20010032099A (ko) 2001-04-16
NZ504420A (en) 2003-08-29
PL194597B1 (pl) 2007-06-29
CN1285742A (zh) 2001-02-28
CO4980891A1 (es) 2000-11-27
EE200000290A (et) 2001-06-15
ID24933A (id) 2000-08-31
JP2001523642A (ja) 2001-11-27
NO20002450D0 (no) 2000-05-11
OA11464A (en) 2003-11-18
TR200001262T2 (tr) 2001-01-22
CA2309966A1 (en) 1999-05-27
PL340500A1 (en) 2001-02-12
AU1160999A (en) 1999-06-07
SK7112000A3 (en) 2000-10-09
IL136122A (en) 2006-07-05
NO20002450L (no) 2000-07-14
EP1030671A1 (fr) 2000-08-30
TW585766B (en) 2004-05-01
CN1243540C (zh) 2006-03-01
SA98190747B1 (ar) 2006-11-04
BR9814035A (pt) 2000-09-26
IL136122A0 (en) 2001-05-20
HUP0100098A2 (hu) 2001-07-30
AU743228B2 (en) 2002-01-24
DZ2649A1 (fr) 2004-12-28
EA200000412A1 (ru) 2000-12-25
BG104428A (en) 2001-08-31
UY25247A1 (es) 2001-05-31
SK286040B6 (sk) 2008-01-07
BG64819B1 (bg) 2006-05-31
KR100599350B1 (ko) 2006-07-12
EA003255B1 (ru) 2003-02-27
WO1999025363A1 (fr) 1999-05-27
MY120461A (en) 2005-10-31

Similar Documents

Publication Publication Date Title
DK1813624T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
DE69612185D1 (de) Bleichverfahren und bleichmittelzusammensetzung
DE69739583D1 (de) Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
DK0622408T3 (da) Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler
DE69638351D1 (de) Sowie zur resektion des distalen und vorderen femurs
EP0626174A3 (en) Method and composition for the prophylaxis and / or treatment of underactive organs.
DE69413051D1 (de) Waschmittelzusammensetzungen enthaltend mittel zur verhinderung des anlaufens von silber
DE69718668D1 (de) Flüssige zusammensetzung, hiv protease inhibitoren und c12-c18 fettsaure enthaltend
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
DE69617088D1 (de) Verfahren zur Herstellung von kristallisiertem Maltit und diesen enthaltenden Kristallinen.
DK0926952T3 (da) Antimikrobiel sammensætning og fremgangsmåde til fremstilling deraf
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
GB9706842D0 (en) Pharmaceutical compositions for the treatment of rhinitis
AU1509999A (en) Herbal drug composition for the prevention and treatment of dementia
ZA977310B (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
IS5482A (is) Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp
DE69831788D1 (de) Verfahren zur Herstellung von halbtransparanten Mischungen aus Poly-Phenyleoxyden und Styrencopolymeren
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69403737D1 (de) Organosiloxan-Zusammensetzung und Herstellungsverfahren
DK1007040T3 (da) Anvendelsen af phanquinon til behandlingen af Alzheimers sygdom
NO992504D0 (no) Sammensetninger for behandling av jord, fremgangsmÕte for fremstilling derav, samt anvendelse
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
WO2000033788A3 (en) Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
EP0635567A3 (en) Method and composition for facilitating the removal of stains from solid surfaces.